A Phase I Study of Lenalidomide in Combination With Decitabine for Patients With High Grade Myelodysplastic Syndromes.
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2013
At a glance
- Drugs Lenalidomide (Primary) ; Decitabine
- Indications Myelodysplastic syndromes
- Focus Adverse reactions
- 19 Sep 2012 Planned End Date changed from 1 Mar 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 19 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Mar 2009 Actual initiation date changed from Jan 2009 to Mar 2009 as reported by ClinicalTrials.gov.